Medicare Enrolled

Dr. Marilyn Raymond, M.D.

Medical Oncology · West Palm Beach, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1309 N FLAGLER DR, West Palm Beach, FL 33401
5613664100
Registered in NPPES since 2005
NPI: 1316943491 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Raymond from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raymond? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Raymond

Dr. Marilyn Raymond is a medical oncology specialist in West Palm Beach, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Raymond performed 40,611 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Raymond received a total of $9,571 from 74 pharmaceutical and/or device companies across 533 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Raymond is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 37% volume in FL $9,571 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 74719 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
40,611
Medicare services
Top 37% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Anti-nausea injection (aprepitant) 11,180 $1 $5
Filgrastim injection (Zarxio) for white blood cells
An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram.
9,540 $0 $2
Denosumab injection (Prolia/Xgeva) 4,500 $18 $51
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
4,340 $0 $1
Injection, fulvestrant, 25 mg 1,680 $7 $132
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
1,420 $6 $23
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,323 $0 $3
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,223 $8 $29
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,208 $8 $9
Anti-nausea injection (Aloxi/palonosetron) 920 $1 $28
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
694 $65 $239
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
437 $102 $339
Anti-nausea injection (ondansetron/Zofran) 256 $0 $9
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
244 $102 $378
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
239 $12 $61
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
199 $6 $69
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
172 $11 $69
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
156 $25 $89
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
144 $23 $84
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
102 $1 $3
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
89 $47 $189
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
76 $144 $474
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 75 $401 $680
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
72 $1,166 $3,710
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
64 $52 $178
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
44 $178 $550
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
43 $16 $56
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
39 $22 $79
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
38 $47 $344
New patient office visit, complex (60-74 min) 28 $174 $585
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
22 $107 $440
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
17 $1 $6
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $44 $147
CT scan of chest, without contrast
A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye.
12 $37 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.5% high complexity
89.3% medium
9.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,571
Total received (2018-2024)
Avg $1,367/year across 7 years
Top 46% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
533
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,657
2023
$2,371
2022
$1,735
2021
$940
2020
$403
2019
$613
2018
$851

Payments by company (2024)

Janssen Biotech, Inc.
$368
Daiichi Sankyo Inc.
$270
ABBVIE INC.
$241
Merck Sharp & Dohme LLC
$231
Incyte Corporation
$186
Celgene Corporation
$181
GlaxoSmithKline, LLC.
$158
Menarini Silicon Biosystems, Inc.
$98
AstraZeneca Pharmaceuticals LP
$79
Kyowa Kirin, Inc.
$64
Takeda Pharmaceuticals U.S.A., Inc.
$64
GENZYME CORPORATION
$63
Ipsen Biopharmaceuticals, Inc
$57
Karyopharm Therapeutics Inc.
$43
Tempus AI, Inc
$41
ARRAY BIOPHARMA INC
$41
Adaptive Biotechnologies Corporation
$41
Eisai Inc.
$38
PFIZER INC.
$35
Gilead Sciences, Inc.
$31
TerSera Therapeutics LLC
$31
JAZZ PHARMACEUTICALS INC.
$30
Fennec Pharmaceuticals, Inc.
$30
Mirati Therapeutics, Inc.
$25
Kite Pharma, Inc.
$23
ADC Therapeutics America, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$22
Alexion Pharmaceuticals, Inc.
$21
BeiGene USA, Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Regeneron Healthcare Solutions, Inc.
$18
Novartis Pharmaceuticals Corporation
$17
EMD Serono, Inc.
$16
Azurity Pharmaceuticals, Inc.
$16
Napo Pharmaceuticals Inc
$15
Top 3 companies account for 33.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$703
Celgene Corporation
$588
Daiichi Sankyo Inc.
$517
Incyte Corporation
$502
NanoString Technologies, Inc.
$492
Merck Sharp & Dohme LLC
$462
Novartis Pharmaceuticals Corporation
$461
AstraZeneca Pharmaceuticals LP
$384
Eisai Inc.
$339
PFIZER INC.
$327
Takeda Pharmaceuticals U.S.A., Inc.
$293
GlaxoSmithKline, LLC.
$271
Lilly USA, LLC
$262
ABBVIE INC.
$241
Ipsen Biopharmaceuticals, Inc
$239
Myriad Genetic Laboratories, Inc.
$231
Seagen Inc.
$220
Pharmacyclics LLC, An AbbVie Company
$203
Astellas Pharma US Inc
$202
GENZYME CORPORATION
$186
E.R. Squibb & Sons, L.L.C.
$155
Bayer HealthCare Pharmaceuticals Inc.
$141
Kyowa Kirin, Inc.
$126
ARRAY BIOPHARMA INC
$107
JAZZ PHARMACEUTICALS INC.
$107
Menarini Silicon Biosystems, Inc.
$98
TerSera Therapeutics LLC
$97
Amgen Inc.
$92
BeiGene USA, Inc.
$84
EMD Serono, Inc.
$72
Gilead Sciences, Inc.
$70
Pharmacyclics LLC, an AbbVie Company
$65
Alexion Pharmaceuticals, Inc.
$58
Seattle Genetics, Inc.
$57
Adaptive Biotechnologies Corporation
$55
Genentech USA, Inc.
$51
Regeneron Healthcare Solutions, Inc.
$50
Clovis Oncology, Inc.
$48
Sobi, Inc
$48
Mirati Therapeutics, Inc.
$43
Karyopharm Therapeutics Inc.
$43
Heron Therapeutics, Inc.
$43
Tempus AI, Inc
$41
Aurobindo Pharma USA, Inc.
$41
EISAI INC.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Puma Biotechnology, Inc.
$32
Merck Sharp & Dohme Corporation
$32
Bayer Healthcare Pharmaceuticals Inc.
$32
Fennec Pharmaceuticals, Inc.
$30
Dova Pharmaceuticals
$27
Aveo Pharmaceuticals, Inc.
$27
Janssen Scientific Affairs, LLC
$25
TOLMAR Pharmaceuticals, Inc.
$24
Kite Pharma, Inc.
$23
ADC Therapeutics America, Inc.
$22
Taiho Oncology, Inc.
$22
SERVIER PHARMACEUTICALS LLC
$22
TESARO, Inc.
$22
Blueprint Medicines Corporation
$20
RECORDATI_RARE_DISEASES_INC.
$20
AbbVie, Inc.
$20
Cumberland Pharmaceuticals, Inc.
$19
Deciphera Pharmaceuticals Inc.
$19
AVEO Pharmaceuticals, Inc.
$18
Sirtex Medical Inc
$18
TG THERAPEUTICS, INC.
$17
CTI BioPharma Corp.
$17
Azurity Pharmaceuticals, Inc.
$16
AbbVie Inc.
$15
Napo Pharmaceuticals Inc
$15
Stemline Therapeutics Inc.
$15
Exelixis Inc.
$11
Veracyte, Inc.
$4
Top 3 companies account for 18.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AUGTYRO · AYVAKIT · Alecensa · Aliqopa · BAVENCIO · BRAFTOVI · BRUKINSA · CABLIVI · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · FOTIVDA · GELCLAIR CONCENTRATED ORAL GEL · GILOTRIF · HYQVIA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · JEMPERLI · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LOCAMETZ · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NERLYNX · Nerlynx · Nexavar · Nplate · Nubeqa · ONIVYDE · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PROSIGNA ASSAY · Pedmark · Perjeta · Pomalyst · Poteligeo · PreciseTumor · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rubraca · SANCUSO · SARCLISA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Stivarga · Sustol · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONVENDI · VPRIV · Venclexta · Vitrakvi · Vonjo · XALKORI · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical oncology specialist in West Palm Beach?
Compare medical oncologists in the West Palm Beach area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists in nearby ZIP areas
21
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
GOOD SAMARITAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Raymond is a mixed practice specialist, with moderate Medicare volume, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Raymond experienced with anti-nausea injection (aprepitant)?
Based on Medicare claims data, Dr. Raymond performed 11,180 anti-nausea injection (aprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Raymond receive payments from pharmaceutical companies?
Yes. Dr. Raymond received a total of $9,571 from 74 companies across 533 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raymond's costs compare to other medical oncologists in West Palm Beach?
Dr. Raymond's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raymond) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →